RAS-001

N/A

Report date: 2025/01/26 17:43:39
NME

Base Information

Drug NameRAS-001
Drug Alias Nameantisense Ksr-1 inhibitor (Memorial Sloan-Kettering Center)antisense Ras-1 inhibitor (Ras Therapeutics)antisense Ksr-1 inhibitor (Ras Therapeutics)antisense Ras-1 inhibitor (Memorial Sloan-Kettering Center)RAS-001
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGTPase Ras inhibitors
TargetsGTPase Ras
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesRas Therapeutics Inc
Inactive CompaniesMemorial Sloan Kettering Cancer Center
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A